RECURRENT VISUAL PATHWAY GLIOMA

Clinical trials for RECURRENT VISUAL PATHWAY GLIOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT VISUAL PATHWAY GLIOMA trials appear

Sign up with your email to follow new studies for RECURRENT VISUAL PATHWAY GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for kids with Tough-to-Treat brain tumors

Disease control Ongoing

This study tested a drug called selumetinib for children and young adults whose low-grade brain tumors came back or didn't respond to prior treatment. The goal was to find a safe dose and see if the drug could shrink or control the tumors. Participants took the drug as a pill twi…

Matched conditions: RECURRENT VISUAL PATHWAY GLIOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

RECURRENT VISUAL PATHWAY GLIOMA

Get alerted when new RECURRENT VISUAL PATHWAY GLIOMA trials appear

New hope for kids with Tough-to-Treat brain tumors